Oruka Therapeutics ORKA
NASDAQ ORKA
$84.52 +1.10 (+1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oruka Therapeutics (ORKA) Return on Assets [ROA] (2011 - 2024)

Updated

Oruka Therapeutics (ORKA) recorded Return on Assets [ROA] of -20.41% in Q2 2024, down 5.18 percentage points from -15.23% a year earlier and down 4.31 percentage points from the prior quarter.

Analysis

Oruka Therapeutics (ORKA) Return on Assets [ROA] (2011 - 2024) Analysis & Trends

For FY2023, Oruka Therapeutics reported Return on Assets [ROA] of -13.19%, up 7.05 percentage points from FY2022.

  • Annual Return on Assets [ROA] has a five-year change of +69.49 percentage points (FY2018 to FY2023).
  • Across earlier years, Return on Assets [ROA] came in at -20.25% in FY2022 (+16.44 pp), -36.68% in FY2021 (-3.65 pp), -33.03% in FY2020 (+38.35 pp) and -71.38% in FY2019 (+11.30 pp).
  • The Q2 2024 figure is the lowest quarterly Return on Assets [ROA] since Q4 2022.
  • On a year-over-year basis, Return on Assets [ROA] rose in six of the last eight quarters, with an average year-over-year change of +8.55 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 59.12 percentage points in Q3 2019, against a drop of 14.55 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at -16.10% (Q1 2024), -13.86% (Q4 2023) and -13.51% (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 10.47%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 4.65%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 28.37%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.10%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 9.29%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -6.13%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 2.14%
10 Oruka Therapeutics 5.24 Bn 3.30 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -20.41%
Mar 31, 2024 -16.10%
Dec 31, 2023 -13.86%
Sep 30, 2023 -13.51%
Jun 30, 2023 -15.23%
Mar 31, 2023 -18.78%
Dec 31, 2022 -22.53%
Sep 30, 2022 -31.00%
Jun 30, 2022 -33.91%
Mar 31, 2022 -34.91%
Dec 31, 2021 -33.57%
Sep 30, 2021 -29.91%
Jun 30, 2021 -23.86%
Mar 31, 2021 -20.93%
Dec 31, 2020 -19.02%
Sep 30, 2020 -18.36%
Jun 30, 2020 -52.41%
Mar 31, 2020 -64.24%
Dec 31, 2019 -59.31%
Sep 30, 2019 -56.50%
API Access

Oruka Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ORKA&period=max&api_key=YOUR_API_KEY